QSAM Biosciences, Inc.
OTC: QSAM0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Douglas R. Baum
- Employees
- 4
- Headquarters
- Austin, United States
- IPO year
- 2012
- Market cap
- $18.4K
- Website
- https://qsambio.com
Loading QSAM…
Loading profile data…Frequently asked questions about QSAM
What does QSAM Biosciences, Inc. (QSAM) do?
Based in Austin, Texas, QSAM Biosciences, Inc. is dedicated to advancing nuclear medicine for cancer and related illnesses. A key component of their pipeline is CycloSam (Samarium-153 DOTMP), a radiopharmaceutical currently in clinical development that specifically targets bone. The company holds a licensing agreement with IGL Pharma, Inc. Found...
Where does QSAM trade?
QSAM Biosciences, Inc. (QSAM) trades on the Other OTC.
What sector is QSAM in?
QSAM Biosciences, Inc. (QSAM) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of QSAM Biosciences, Inc.?
Douglas R. Baum is the chief executive officer of QSAM Biosciences, Inc. (QSAM).
Where is QSAM Biosciences, Inc. headquartered?
QSAM Biosciences, Inc. is headquartered in United States.
Does QSAM pay a dividend?
QSAM Biosciences, Inc. (QSAM) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did QSAM go public?
QSAM Biosciences, Inc. (QSAM) completed its initial public offering in 2012.